Robust sampling of defective pathways in Alzheimer's disease. Implications in drug repositioning

dc.contributor.author	Fernández Martínez, Juan Luis
dc.contributor.author	Álvarez Machancoses, Óscar
dc.contributor.author	Andrés Galiana, Enrique Juan de
dc.contributor.author	Bea, Guillermina
dc.contributor.author	Kloczkowski, Andrzej
dc.date.accessioned	2021-01-27T10:19:09Z
dc.date.available	2021-01-27T10:19:09Z
dc.date.issued	2020
dc.identifier.citation	International Journal of Molecular Sciences, 21(10), p. 3594- (2020); doi:10.3390/ijms21103594
dc.identifier.uri	http://hdl.handle.net/10651/57432
dc.description.sponsorship	National Science Foundation (NSF, USA) [DBI 1661391]; United States Department of Health & Human Services, National Institutes of Health (NIH, USA) [R01 GM127701, R01 GM127701-01S1]
dc.format.extent	p. 3594-
dc.language.iso	eng
dc.relation.ispartof	International Journal of Molecular Sciences
dc.rights	©2020 los autores
dc.rights	CC Reconocimiento 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	WOS:000539312100190
dc.title	Robust sampling of defective pathways in Alzheimer's disease. Implications in drug repositioning
dc.type	journal article
dc.identifier.doi	10.3390/ijms21103594
dc.relation.publisherversion	http://dx.doi.org/10.3390/ijms21103594
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Este ítem está sujeto a una licencia Creative Commons